Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen L Fedor

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Medicine|November 16, 2004
Practical methods for tissue microarray constructionHelen L Fedor, Angelo M De Marzo
Asian Journal of Andrology|February 7, 2012
Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide dataThomas A Dunn, Helen L Fedor, Angelo M De Marzo, et al.
The Prostate|January 1, 2008
A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganismsKaren S Sfanos, Jurga Sauvageot, Helen L Fedor, et al.
The Prostate|October 12, 2013
Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository networkMedha Darshan, Qizhi Zheng, Helen L Fedor, et al.
Cancer|June 8, 2012
An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomyEmmanuel S Antonarakis, Daniel Keizman, Zhe Zhang, et al.
The Prostate|September 16, 2004
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarraysDennis A Faith, William B Isaacs, James D Morgan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrencePaul J Dluzniewski, Ming-Hsi Wang, Siqun Lilly Zheng, et al.
European Urology|June 11, 2015
Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk MenAshley E Ross, Michael H Johnson, Kasra Yousefi, et al.
The New England Journal of Medicine|September 4, 2014
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancerEmmanuel S Antonarakis, Changxue Lu, Hao Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Medicine|November 16, 2004
Practical methods for tissue microarray constructionHelen L Fedor, Angelo M De Marzo
Asian Journal of Andrology|February 7, 2012
Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide dataThomas A Dunn, Helen L Fedor, Angelo M De Marzo, et al.
The Prostate|January 1, 2008
A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganismsKaren S Sfanos, Jurga Sauvageot, Helen L Fedor, et al.
The Prostate|October 12, 2013
Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository networkMedha Darshan, Qizhi Zheng, Helen L Fedor, et al.
Cancer|June 8, 2012
An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomyEmmanuel S Antonarakis, Daniel Keizman, Zhe Zhang, et al.
The Prostate|September 16, 2004
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarraysDennis A Faith, William B Isaacs, James D Morgan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrencePaul J Dluzniewski, Ming-Hsi Wang, Siqun Lilly Zheng, et al.
European Urology|June 11, 2015
Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk MenAshley E Ross, Michael H Johnson, Kasra Yousefi, et al.
The New England Journal of Medicine|September 4, 2014
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancerEmmanuel S Antonarakis, Changxue Lu, Hao Wang, et al.
Pageof 1